April 25, 2001 | ||
|
||
![]() |
||
|
||
![]() |
||
![]() |
On April 25, 2001, Olympus Optical Co., Ltd. (President: Masatoshi Kishimoto, hereinafter called "Olympus") and Terumo Corporation (President: Takashi Wachi, hereinafter called "Terumo") entered into an alliance agreement relating to product development, manufacture, and sales in the medical equipment field.
Especially, Olympus and Terumo will develop minimally invasive diagnosis/treatment devices -the major trend of future medical treatment-which reduce the pain or suffering of patients. Both companies will establish a closer relationship with respect to development and sales in areas of heart surgery, gastroenterology , and urology. The five-year target sales figure of both companies is an annual total of ten billion yen or more. |
![]() |
Olympus and Terumo recognized that trends in future medical treatment are represented by two key words: "minimally invasive" and "cost-effective" medical treatment. Accordingly both companies decided to combine our core technologies to develop and produce new next-generation devices that are highly competitive in the world market under technical alliance between Olympus and Terumo. |
![]() |
The strength of Olympus is optical/digital technology in medical and health-care fields. The company develops medical systems such as endoscopes, microscopes, and clinical analyzers.
Especially in the endoscopic domain, Olympus develops and offers comprehensive diagnosis/treatment devices for clinicians involved in a variety of areas such as surgery as well as gastroenterology systems. Terumo has a high market share of disposable medical devices, nutriment alignments, and I.V. solutions. The company has the most advanced technologies with respect to the medical treatment of cardiovascular systems such as PTCA balloon cathetersh*1, coronary stentsh*2, and heart-lung machine systemsh*3. The company also offers prominent technologies in medicines and home medical care. |
![]() |
Both companies are pioneers in advanced medical equipment and are expanding businesses for developing minimally invasive diagnosis/treatment devices. By the integration of Olympus's optical/digital technologies and Terumo's medical expertise, Olympus and Terumo can share the advantages of the core technologies, manufacturing technologies, and sales networks to produce higher synergy effects, developing and popularizing minimally invasive and cost-effective medical equipments needed for future medical treatment. |
![]() |
The scope of technical cooperation covers broad business areas. For the present, we will start joint development of next-generation treatment devices used in heart surgery, gastroenterology, and urology.
The five-year target sales figure of both companies, only in these areas, is expected to be an annual total of 10 billion yen or more. We are also considering other businesses or development themes for future cooperation. At present, there is no plan to establish a new capital relationship between Olympus and Terumo. |
![]() |
Joint Development Theme | |||||||||||||
![]() |
|
||||||||||||
![]() |
Glossary | |||||||||||||||||||||||||
![]() |
|
||||||||||||||||||||||||
![]() |
About Olympus Optical Co., Ltd. | |||||||||||||||
![]() |
|
||||||||||||||
![]() |
|||||||||||||||
![]() |
Olympus has developed fiberscopes and videoscopes with which internal organs can be directly observed since the company developed the first photogastroscope in 1950. Today we are expanding our business including the development of instruments and devices for medical treatment, as well as those for diagnosis. Olympus has the largest market share and the most advanced technology of endoscopes in the world. The company is contributing to the treatment of diseases and the early detection of cancers. | ||||||||||||||
![]() |
About Terumo Corporation | |||||||||||||||
![]() |
|
||||||||||||||
![]() |
|||||||||||||||
![]() |
Terumo has a high market share of disposable medical devices, nutriment alignments, and I.V. solution in Japan and overseas. The company has the largest market share of guidewires for angiography and treatment in the world. We have advanced technologies with respect to angiographic catheters, stents-the first ever produced in Japan-and heart-lung machine systems. | ||||||||||||||
![]() |
![]() |
*Olympus Optical Co., Ltd. was changed to OLYMPUS CORPORATION as of October 1, 2003.
- Press releases are company announcements that are directed at the news media.
- Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.
- Company names and product names specified are trademarks of their respective owners.